Alabama is currently home to 1229 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Birmingham, Mobile, Huntsville and Anniston. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
An Accessible and Inclusive Artificial Intelligence Assisted Chronic Disease Self-Management Telehealth Platform
NCT05481593
Recruiting
The purpose of this study to pilot test an accessible and inclusive artificial intelligence (AI)-assisted, individualized, family-focused lifestyle modification intervention (AI4CHRON) for health-related quality of life for adults with impaired mobility and chronic medical conditions.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/16/2024
Locations: University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Disability Physical, Chronic Condition, Chronic Conditions, Multiple
Register for Updates
Accessible and Inclusive Diabetes Telecoaching Self-Management Program
NCT04927377
Recruiting
The purpose of this study is to develop and pilot test an accessible and inclusive Artificial Intelligence (AI)-assisted, individualized, family-focused lifestyle modification intervention (AI4DM) for glycemic control in people with disabilities.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
10/16/2024
Locations: University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Diabete Type 2, Disability Physical
Register for Updates
Reducing Vertical Transmission of Hepatitis B in Africa
NCT04704024
Recruiting
Hepatitis B virus is an infection that can be easily transmitted from women to newborns at the time of delivery. Our objective is to identify novel options that are effective and safe in preventing perinatal transmission of hepatitis B in Africa. The REVERT-B study (Reducing Vertical Transmission of Hepatitis B in Africa) is a clinical trial designed to test a new strategy of using antiviral medication in high-risk pregnant women and newborns to reduce the risk of hepatitis B transmission. The s... Read More
Gender:
FEMALE
Ages:
Between 16 years and 50 years
Trial Updated:
10/16/2024
Locations: University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Hepatitis B Infection
Register for Updates
KT Tape for Pediatric Clavicle Fractures
NCT04161534
Recruiting
Clavicle fractures in children are mostly managed non-operatively since they have an overall high union rate (95%) and a "good" functional outcome following nonoperative treatment. However, the downside of such a conservative approach is that patients have to live with pain and disability until the fracture heals. To minimize this, fractures are usually immobilized with a sling. There have been no studies looking at clavicle fractures treated with kinesiology (elastic) tape. No adverse effects... Read More
Gender:
ALL
Ages:
Between 7 years and 17 years
Trial Updated:
10/16/2024
Locations: Children's Hospital of Alabama, Birmingham, Alabama
Conditions: Clavicle Fracture
Register for Updates
TSC Biosample Repository and Natural History Database
NCT05676099
Recruiting
The TSC Biosample Repository collects and stores samples of blood, DNA, and tissues that scientists can request to use in their research. The samples we collect are all linked to clinical data in the TSC Natural History Database. The TSC Natural History Database captures clinical data to document the impact of the disease on a person's health over his or her lifetime. This data may be collected retrospectively or prospectively.
Gender:
ALL
Ages:
All
Trial Updated:
10/15/2024
Locations: University of Alabama Birmingham, Birmingham, Alabama
Conditions: Tuberous Sclerosis, Lymphangioleiomyomatosis
Register for Updates
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
NCT02977780
Recruiting
This research study is studying several investigational drugs as a possible treatment for Glioblastoma (GBM). The drugs involved in this study are : * Abemaciclib * Temozolomide (temodar) * Neratinib * CC115 * QBS10072S
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/15/2024
Locations: University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Glioblastoma
Register for Updates
Prenatal Behavioral Intervention to Prevent Maternal Cytomegalovirus (CMV) in Pregnancy
NCT04615715
Recruiting
This study will evaluate whether a brief prenatal clinic-based cytomegalovirus (CMV) risk-reduction behavioral intervention will prevent maternal CMV infections during pregnancy in women.
Gender:
FEMALE
Ages:
Between 14 years and 39 years
Trial Updated:
10/14/2024
Locations: University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Maternal Cytomegalovirus Infections, Cytomegalovirus Congenital
Register for Updates
The Fit with Us Study
NCT06207084
Recruiting
The purpose of this 32 week study is to use an innovative experimental design known as SMART (Sequential Multiple Assignment Randomized Trial), which will allow us to determine the best way to sequence the delivery of teleexercise (referred to as an adaptive intervention), combined with predictive analytics on participant adherence in a stepped program of physical activity interventions. All 257 participants will have access to a library of recorded video exercise content, and a weekly wellness... Read More
Gender:
ALL
Ages:
Between 18 years and 64 years
Trial Updated:
10/11/2024
Locations: Wellness, Health and Research Facility, Birmingham, Alabama
Conditions: Mobility Limitations, Disability Physical, Telehealth, Health Coaching, Physical Activity, Behavior, Health, eHealth, Health Literacy, Self Efficacy, Fatigue, Usability, Predictive Model
Register for Updates
Allopurinol Improves Heart Function in African Americans With Resistant Hypertension
NCT05888233
Recruiting
African American adults in the United States have the highest prevalence rate of high blood pressure (hypertension) and heart failure in the world. African Americans with treatment resistant hypertension have higher levels of the enzyme - xanthine oxidase compared to Caucasians. This trial will test if administration of the xanthine oxidase inhibitor - Allopurinol (commonly used in the treatment of gout), given over a period of 8 weeks, will improve heart function, exercise ability and quality o... Read More
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
10/11/2024
Locations: Birmingham VA Medical Center, Birmingham, AL, Birmingham, Alabama
Conditions: Heart Failure Preserved Ejection Fraction, Resistant Hypertension
Register for Updates
A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19
NCT05386472
Recruiting
The purpose of this clinical trial is to learn about how study medicine (Paxlovid, which contains nirmatrelvir and ritonavir) is changed and eliminated from the body, as well as its safety, and the extent to which side effects can be tolerated for treatment of pregnant women with mild or moderate COVID-19 compared to non-pregnant women with mild or moderate COVID-19. This study is seeking participants who: * are expecting a healthy baby and are in their second or third trimester pregnancy and... Read More
Gender:
FEMALE
Ages:
Between 18 years and 50 years
Trial Updated:
10/11/2024
Locations: University of Alabama at Birmingham Women & Infant Center, Birmingham, Alabama
Conditions: COVID-19
Register for Updates
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
NCT01429389
Recruiting
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
10/11/2024
Locations: University of Alabama Birmingham, Birmingham, Alabama
Conditions: Down Syndrome, Fetal Aneuploidy
Register for Updates
A Motion Exergaming Approach for Symptom Management: HNC
NCT04632654
Recruiting
This overall objective of the RCT is to test an intervention to overcome the PA barriers for head and neck cancer (HNC) patients during the first 6 months after their treatment. PAfitME stands for a personalized Physical Activity intervention with fitness graded Motion Exergames. PAfitME is delivered via a tested mix of FaceTime calls and home visits, uses commercially available exergaming platforms (Nintendo Switch). We propose the following specific aims: (1) When compared to an attention cont... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/10/2024
Locations: University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Head and Neck Cancer
Register for Updates